| Primary |
| Asthma |
49.7% |
| Chronic Obstructive Pulmonary Disease |
18.4% |
| Drug Use For Unknown Indication |
15.0% |
| Product Used For Unknown Indication |
6.2% |
| Emphysema |
2.3% |
| Hypertension |
2.0% |
| Depression |
1.3% |
| Bronchitis |
0.8% |
| Angina Pectoris |
0.5% |
| Dizziness |
0.5% |
| Irritable Bowel Syndrome |
0.5% |
| Nasopharyngitis |
0.5% |
| Wheezing |
0.4% |
| Aortic Valve Incompetence |
0.3% |
| Atrial Fibrillation |
0.3% |
| Lung Disorder |
0.3% |
| Asthma Exercise Induced |
0.3% |
| Bronchiectasis |
0.3% |
| Bronchospasm |
0.3% |
| Constipation |
0.3% |
|
| Product Quality Issue |
20.6% |
| Pharmaceutical Product Complaint |
19.2% |
| Drug Ineffective |
12.0% |
| Wheezing |
8.5% |
| Dyspnoea |
7.2% |
| Asthma |
4.2% |
| Tremor |
3.9% |
| Throat Irritation |
2.8% |
| Respiratory Disorder |
2.5% |
| Muscle Spasms |
2.3% |
| Pneumonia |
2.1% |
| Death |
1.8% |
| Therapeutic Response Decreased |
1.8% |
| Weight Increased |
1.8% |
| Dysphonia |
1.6% |
| Heart Rate Increased |
1.6% |
| Rash |
1.6% |
| Weight Decreased |
1.6% |
| Adverse Event |
1.4% |
| Cough |
1.4% |
|
| Secondary |
| Drug Use For Unknown Indication |
37.8% |
| Asthma |
28.3% |
| Chronic Obstructive Pulmonary Disease |
9.3% |
| Product Used For Unknown Indication |
3.8% |
| Emphysema |
3.2% |
| Supraventricular Tachycardia |
1.9% |
| Respiratory Disorder |
1.8% |
| Epilepsy |
1.7% |
| Dyspnoea |
1.6% |
| Dermatitis |
1.4% |
| Atrial Fibrillation |
1.4% |
| Grand Mal Convulsion |
1.3% |
| Thrombosis Prophylaxis |
1.3% |
| Depression |
1.0% |
| Rash |
1.0% |
| Tachycardia Paroxysmal |
0.8% |
| Hypertension |
0.8% |
| Sleep Disorder |
0.6% |
| Bronchitis Chronic |
0.6% |
| Conjunctivitis |
0.6% |
|
| Death |
40.0% |
| Asthma |
8.2% |
| Wheezing |
7.4% |
| Status Asthmaticus |
5.7% |
| Respiratory Arrest |
4.4% |
| Pneumonia |
3.8% |
| Respiratory Failure |
3.4% |
| Drug Ineffective |
2.9% |
| Dyspnoea |
2.9% |
| Toxic Epidermal Necrolysis |
2.5% |
| Upper Respiratory Tract Infection |
2.5% |
| Vomiting |
2.5% |
| Tremor |
2.3% |
| Chronic Obstructive Pulmonary Disease |
1.9% |
| Weight Decreased |
1.9% |
| Pain |
1.7% |
| Throat Irritation |
1.7% |
| Dysphonia |
1.5% |
| Muscle Spasms |
1.5% |
| Chest Discomfort |
1.3% |
|
| Concomitant |
| Asthma |
21.3% |
| Drug Use For Unknown Indication |
19.2% |
| Product Used For Unknown Indication |
15.8% |
| Chronic Obstructive Pulmonary Disease |
11.1% |
| Hypertension |
6.1% |
| Pain |
2.8% |
| Osteoporosis |
2.8% |
| Depression |
2.6% |
| Emphysema |
2.6% |
| Rheumatoid Arthritis |
1.9% |
| Arthritis |
1.9% |
| Dyspnoea |
1.7% |
| Prophylaxis |
1.5% |
| Diabetes Mellitus |
1.5% |
| Insomnia |
1.3% |
| Gastrooesophageal Reflux Disease |
1.3% |
| Hypersensitivity |
1.3% |
| Type 2 Diabetes Mellitus |
1.1% |
| Back Pain |
1.0% |
| Hormone Replacement Therapy |
1.0% |
|
| Dyspnoea |
9.4% |
| Vomiting |
9.1% |
| Weight Decreased |
8.0% |
| Weight Increased |
6.6% |
| Wheezing |
5.8% |
| Asthma |
5.2% |
| Drug Ineffective |
5.2% |
| Urticaria |
4.6% |
| Pharmaceutical Product Complaint |
4.4% |
| Somnolence |
4.4% |
| Pyrexia |
4.2% |
| Vision Blurred |
4.2% |
| Tremor |
4.1% |
| Death |
3.9% |
| Myocardial Infarction |
3.8% |
| Pneumonia |
3.8% |
| Nausea |
3.7% |
| Pain In Extremity |
3.5% |
| Respiratory Failure |
3.1% |
| White Blood Cell Count Decreased |
3.1% |
|
